BioPharmSignal logoBioPharmSignal

Biotech News

Integra Announces Pricing of Senior Secured Notes

Integra LifeSciences (IART)Integra LifeSciencesCompany update

PRINCETON, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) (the “Company”) today announced the pricing of $450,000,000 aggregate principal amount of 9.500% senior secured notes due 2033 (the “Notes”). The Notes will be general senior secured

Related news

IARTIntegra LifeSciences2026-10-02 12:00 EST

Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B

IARTIntegra LifeSciences2026-10-21 10:00 EST

Integra LifeSciences Reports Third Quarter 2026 Financial Results

EHCEncompass Health Corporation2026-08-10 20:30 EST

Encompass Health prices private offering of additional 5.875% senior notes due 2034

EHCEncompass Health Corporation2026-08-10 12:28 EST

Encompass Health announces launch of private offering of 5.875% senior notes due 2034

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-10-21 10:00 EST

Integra LifeSciences Reports Third Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-10-19 20:05 EST

Integra Announces Completion of Refinancing Transactions

IARTIntegra LifeSciences2026-10-16 12:40 EST

Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

IARTIntegra LifeSciences2026-10-09 21:22 EST

Integra Announces Pricing of Senior Secured Notes

IARTIntegra LifeSciences2026-10-06 12:30 EST

Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026

Stock data

Close
11.84 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States